Seer Inc (SEER)

• Market cap: $118M
• 1 day: 0.00%
• 5 days: -1.50%
• 1 month: 4.79%
• 3 months: -16.53%
• 6 months: 3.14%
• Year to date: -15.45%
• 1 year: 17.96%
• 5 years: -96.51%
• 10 years: -96.51%
• Sector: Healthcare
• Industry: Biotechnology

About: Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

Employees: 134

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 2 (+1) [Q4]

80% more call options, than puts

Call options by funds: $9K | Put options by funds: $5K

18% more capital invested

Capital invested by funds: $57.8M [Q3] → $68.4M (+$10.7M) [Q4]

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

2.75% more ownership

Funds ownership: 51.17% [Q3] → 53.92% (+2.75%) [Q4]

1% more funds holding

Funds holding: 70 [Q3] → 71 (+1) [Q4]

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23